Evaluation of Prevenar 13's Vaccine Response in Patients Hospitalized in Infectious Disease Department for Sepsis
Latest Information Update: 07 Aug 2023
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections; Sepsis
- Focus Therapeutic Use
- Acronyms Vaccis
- 02 Aug 2023 Status changed from active, no longer recruiting to completed.
- 26 Jul 2023 Planned End Date changed from 19 Jun 2023 to 1 Aug 2023.
- 26 Jul 2023 Planned primary completion date changed from 19 Jun 2023 to 1 Aug 2023.